College of Veterinary Medicine, Southwest University, Chongqing, 402460, China; Immunology Research Center, Medical Research Institute, Southwest University, Chongqing, 402460, China.
Chongqing Academy of Animal Sciences, Chongqing, 402460, China.
Theriogenology. 2023 Aug;206:40-48. doi: 10.1016/j.theriogenology.2023.04.027. Epub 2023 May 6.
Evidence has shown that microRNA-665 (miR-665) is highly expressed in the mid-luteal phase compared with the early and end-luteal phase of the corpus luteum (CL) life cycle. However, whether miR-665 is a positive regulator of the life span of the CL is still unknown. The objective of this study is to explore the effect of miR-665 on the structural luteolysis in the ovarian CL. In this study, the targeting relationship between miR-665 and hematopoietic prostaglandin synthase (HPGDS) was firstly verified by dual luciferase reporter assay. Then, quantitative real-time PCR (qRT-PCR) was used to detect the expression of miR-665 and HPGDS in luteal cells. Following miR-665 overexpression, the apoptosis rate of the luteal cells was determined using flow cytometry; B-cell lymphoma-2 (BCL-2) and caspase-3 mRNA and protein were measured using qRT-PCR and Western blot (WB) analysis. Finally, the DP1 and CRTH2 receptors of PGD, a synthetic product of HPGDS, were localized using immunofluorescence. Results confirmed that HPGDS was a direct target gene of miR-665, and miR-665 expression was negatively correlated with HPGDS mRNA expression in luteal cells. Meanwhile, after miR-665 was overexpressed, the apoptotic rate of the luteal cells showed a significant decrease (P < 0.05) and this was accompanied by elevated expression levels of anti-apoptotic factor BCL-2 mRNA and protein and decreased expression levels of apoptotic factor caspase-3 mRNA and protein (P < 0.01). Moreover, the immune fluorescence staining results showed that the DP1 receptor was also significantly decreased (P < 0.05), but the CRTH2 receptor was significantly increased (P < 0.05) in luteal cells. Overall, these results indicate that miR-665 reduces the apoptosis of luteal cells via inhibiting caspase-3 expression and promoting BCL-2 expression, and the biological function of miR-665 may be attributed to its target gene HPGDS which regulates the balance of DP1 and CRTH2 receptors expression in luteal cells. As a consequence, this study suggests that miR-665 might be a positive regulator of the life span of the CL rather than destroy the integrity of CL in small ruminants.
已有证据表明,与黄体周期的早、晚期相比,miR-665(微小 RNA-665)在黄体中期的表达水平较高。然而,miR-665 是否是黄体寿命的正调控因子仍不清楚。本研究旨在探讨 miR-665 对卵巢黄体结构黄体溶解的影响。在这项研究中,首先通过双荧光素酶报告实验验证了 miR-665 与造血前列腺素合酶(HPGDS)之间的靶向关系。然后,采用定量实时 PCR(qRT-PCR)检测黄体细胞中 miR-665 和 HPGDS 的表达。过表达 miR-665 后,采用流式细胞术检测黄体细胞的凋亡率;采用 qRT-PCR 和 Western blot(WB)分析检测 B 细胞淋巴瘤-2(BCL-2)和半胱氨酸天冬氨酸蛋白酶-3(caspase-3)mRNA 和蛋白的表达。最后,采用免疫荧光定位 PGD 的 DP1 和 CRTH2 受体,PGD 是 HPGDS 的合成产物。结果证实 HPGDS 是 miR-665 的直接靶基因,黄体细胞中 miR-665 的表达与 HPGDS mRNA 的表达呈负相关。同时,过表达 miR-665 后,黄体细胞的凋亡率显著降低(P<0.05),抗凋亡因子 BCL-2 mRNA 和蛋白表达水平升高,凋亡因子 caspase-3 mRNA 和蛋白表达水平降低(P<0.01)。此外,免疫荧光染色结果显示,黄体细胞中 DP1 受体显著减少(P<0.05),而 CRTH2 受体显著增加(P<0.05)。综上所述,miR-665 通过抑制 caspase-3 表达和促进 BCL-2 表达减少黄体细胞凋亡,miR-665 的生物学功能可能归因于其靶基因 HPGDS,HPGDS 调节黄体细胞中 DP1 和 CRTH2 受体表达的平衡。因此,本研究表明 miR-665 可能是黄体寿命的正调控因子,而不是破坏小反刍动物黄体的完整性。